ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

ACS-Roosevelt Fellows Announced

July 29, 1977

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000